Home
Healthcare
Healthcare & Pharmaceuticals
Marburg Hemorrhagic Fever Drug Market Growth & Trends [2031]

Global Marburg Hemorrhagic Fever Drug Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Types (Marburg Vaccine, AVI-7288, TKM-Marburg, and Others) Application (Clinics, Hospitals, Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021-2028

HC-3728
4.6 Rating
212 Pages

Upcoming
82 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

The global Marburg hemorrhagic fever drug market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. Marburg virus causes Marburg viral disease (MVD), which has a case fatality rate of up to 88% but can be reduced significantly with proper patient care.

Marburg virus was first discovered in 1967, following simultaneous epidemic in Marburg and Frankfurt, as well as Belgrade, Serbia. The Filoviridae family includes Marburg and Ebola viruses (filovirus). The two diseases are clinically identical, despite the fact that they are caused by distinct viruses. Both illnesses are uncommon, but they have the potential to generate large-scale epidemics with substantial death rates.

Market Trends, Drivers, Restraints, and Opportunities

Increased research and developments made in the vaccine production is expected to drive the growth for the market over forecast period.
Rise in prevalence of chronic diseases around the world and increasing awareness about disease treatment are expected to raise the growth for the market.
High cost associated with the treatment of Marburg hemorrhagic fever can hamper the growth for the market up to some extent.
Increasing government support for research in drug is expected to act as an opportunity for the market growth.

Scope of Marburg Hemorrhagic Fever Drug Market Report

The report on Marburg hemorrhagic fever drug market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes	Details
Report Title	Marburg Hemorrhagic Fever Drug Market - Global Industry Analysis, Growth, Size, Share, Trends And Forecast
Base Year	2020
Historic Data	2018 & 2019
Forecast Period	2021–2028
Segmentation	Types (Marburg Vaccine, AVI-7288, TKM-Marburg, and Others) Application (Clinics, Hospitals, Others)
Regional Scope	Asia Pacific, North America, Europe, Latin America, and Middle East & Africa
Report Coverage	Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast
Key Players Covered in the Report	GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc.

Marburg Hemorrhagic Fever Drug Market Segment Insights

AVI- 7288 segment is projected to hold significant market share

In the terms of types, the market can be divided into Marburg vaccine, AVI-7288, TKM-Marburg, and Others. The AVI -7288 segment held a considerable share of the market in 2020. AVI-7288 is a positive-charged phosphorodiamidate morpholino oligomer that targets the viral messenger RNA that encodes the Marburg virus nucleoprotein. Its safety in humans has not been established. AVI-7288 has huge potential as a post exposure prophylactic for MARV infection in humans based on efficacy in nonhuman primates and pharmacokinetic studies in humans.

Hospital segment held substantial market share in 2020

Based on applications, the Marburg hemorrhagic fever drug market can be fragmented into clinics, hospitals, and others. The hospitals segment constituted a significant market share in 2020 and is projected to expand at a rapid rate during the forecast period. Treatment for Marburg hemorrhagic fever includes supportive hospital therapy, which includes balancing fluids and electrolytes, maintaining oxygen status and blood pressure, replacing lost blood and clotting components, and treating any aggravating infections.

North America dominates the global market

In terms of regions, the global market can be segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The increased investment in healthcare and presence of global market players in North America is expected to drive the growth for the market in the region over the forecast period. Moreover, increasing awareness regarding chronic diseases can boost the market during the forecast period.

Segments

By Types

Marburg Vaccine
AVI-7288
TKM-Marburg
Others

By Applications

Clinics
Hospitals
Others

By Regions

North America
Europe
Latin America
Asia Pacific
Middle East & Africa

By Key Players

GlaxoSmithKline plc
Arbutus Biopharma
Sarepta Therapeutics
Integrated BioTherapeutics, Inc

Competitive Landscape

Key players in the Marburg hemorrhagic fever drug market include GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Marburg Hemorrhagic Fever Drug Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Marburg Hemorrhagic Fever Drug Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Marburg Hemorrhagic Fever Drug Market - Supply Chain
  4.5. Global Marburg Hemorrhagic Fever Drug Market Forecast
     4.5.1. Marburg Hemorrhagic Fever Drug Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Marburg Hemorrhagic Fever Drug Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Marburg Hemorrhagic Fever Drug Market Absolute $ Opportunity
5. Global Marburg Hemorrhagic Fever Drug Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     5.3.1. Marburg Vaccine
     5.3.2. AVI-7288
     5.3.3. TKM-Marburg
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Marburg Hemorrhagic Fever Drug Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
7. North America Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     7.4.1. Marburg Vaccine
     7.4.2. AVI-7288
     7.4.3. TKM-Marburg
     7.4.4. Others
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
8. Latin America Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     8.4.1. Marburg Vaccine
     8.4.2. AVI-7288
     8.4.3. TKM-Marburg
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
9. Europe Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     9.4.1. Marburg Vaccine
     9.4.2. AVI-7288
     9.4.3. TKM-Marburg
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
10. Asia Pacific Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     10.4.1. Marburg Vaccine
     10.4.2. AVI-7288
     10.4.3. TKM-Marburg
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
11. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     11.4.1. Marburg Vaccine
     11.4.2. AVI-7288
     11.4.3. TKM-Marburg
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Marburg Hemorrhagic Fever Drug Market: Market Share Analysis
  12.2. Marburg Hemorrhagic Fever Drug Distributors and Customers
  12.3. Marburg Hemorrhagic Fever Drug Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. GlaxoSmithKline plc
     12.4.2. Arbutus Biopharma
     12.4.3. Sarepta Therapeutics
     12.4.4. Integrated BioTherapeutics, Inc

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By